Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 26;16(2):e0247792.
doi: 10.1371/journal.pone.0247792. eCollection 2021.

Extraction-free protocol combining proteinase K and heat inactivation for detection of SARS-CoV-2 by RT-qPCR

Affiliations

Extraction-free protocol combining proteinase K and heat inactivation for detection of SARS-CoV-2 by RT-qPCR

Valeria Genoud et al. PLoS One. .

Abstract

Real-time reverse transcription PCR (RT-qPCR) is the gold-standard technique for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection in nasopharyngeal swabs specimens. The analysis by RT-qPCR usually requires a previous extraction step to obtain the purified viral RNA. Unfortunately, RNA extraction constitutes a bottleneck for early detection in many countries since it is expensive, time-consuming and depends on the availability of commercial kits. Here, we describe an extraction-free protocol for SARS-CoV-2 detection by RT-qPCR from nasopharyngeal swab clinical samples in saline solution. The method includes a treatment with proteinase K followed by heat inactivation (PK+HID method). We demonstrate that PK+HID improves the RT-qPCR performance in comparison to the heat-inactivation procedure. Moreover, we show that this extraction-free protocol can be combined with a variety of multiplexing RT-qPCR kits. The method combined with a multiplexing detection kit targeting N and ORF1ab viral genes showed a sensitivity of 0.99 and a specificity of 0.99 from the analysis of 106 positive and 106 negative clinical samples. In conclusion, PK+HID is a robust, fast and inexpensive procedure for extraction-free RT-qPCR determinations of SARS-CoV-2. The National Administration of Drugs, Foods and Medical Devices of Argentina has recently authorized the use of this method.

PubMed Disclaimer

Conflict of interest statement

VG, MStortz, AW, BGB, PV, VD, FRL and VL participate in a Transfer Agreement between Facultad de Ciencias Exactas y Naturales (University of Buenos Aires), National Research Council –CONICET and Inbio Highway (Tandil, Argentina). This agreement was not signed yet at the moment of submission. MSalvatori declares no competing interest.

Figures

Fig 1
Fig 1. Proteinase K improves the performance of the heat inactivation method in RT-qPCR determinations of SARS-CoV-2.
(a-b) Positive (#8, #11, #12, #16, #19, #20) and negative (#1, #2, #3) nasopharyngeal swab samples were processed by heat inactivation (HID, 98°C for 5 min); proteinase K treatment followed by heat inactivation (PK+HID, 55°C for 15 min and 98°C for 5 min) or subjected to RNA extraction (purified RNA). The viral N1 and N2 genes and the human RNase P gene (RP) were amplified and detected by RT-qPCR. (a) CT values obtained from RT-qPCR analysis of the same samples prepared by the three different methods. (b) Representative amplification curves for each gene obtained for one of the positive samples. (c) Amplification efficiencies (EPCR) and initial amount of amplicon copies (n) in PK+HID samples relative to the corresponding HID samples. The median of each measurement is represented with a line in the bars and the lengths of these bars represent the standard error. (d) Positive nasopharyngeal swab samples were subjected to treatment with different concentrations of proteinase K (PK) followed by heat inactivation (55°C for 15 min and 98°C for 5 min). The viral N1 and N2 genes and the human RP gene were amplified and detected by RT-qPCR. ΔCT represents the mean difference between CT values obtained in each analyzed condition and the corresponding to HID samples. Mean ± SEM values are represented (N = 5).
Fig 2
Fig 2. PK+HID method exhibits a similar performance than RNA extraction in RT-qPCR determinations of the SARS-CoV-2 N1 gene.
Positive nasopharyngeal swab samples were processed for RNA extraction (purified RNA) or subjected to treatment with PK 1 mg/ml (55°C for 15 min) followed by heat inactivation at 98°C for 5 min (PK+HID). The viral N1 gene and the human RP gene were amplified and detected by RT-qPCR. CT values obtained for the same samples prepared by the two different methods (N = 27), the line obtained by regression of the data (continuous lines) and 95% confidence bands (pink) are represented. The parameter values obtained from the fitting were: slope = 1.17 ± 0.05 and intercept = -3.4 ± 1.2 (N1 amplicon); slope = 1.0 ± 0.1 and intercept = 1.7 ± 3.0 (RP amplicon).
Fig 3
Fig 3. PK+HID method exhibits a similar performance than RNA extraction in RT-qPCR determinations of the SARS-CoV-2 N and ORF1ab genes.
Positive nasopharyngeal swab samples were processed for RNA extraction (purified RNA) or subjected to treatment with PK 1 mg/ml (55°C for 15 min) followed by heat-inactivation at 98°C for 5 min (PK+HID). The viral N and ORF1ab genes and the human RP gene were amplified and detected by RT-qPCR. (a) CT values obtained for the same samples prepared by the two different methods, the line obtained by regression of the data (continuous lines) and 95% confidence bands (pink) are represented. The parameter values obtained from the fitting were: slope = 1.02 ± 0.04 and intercept = 0.1 ± 0.9 (N amplicon); slope = 1.02 ± 0.04 and intercept = 0.8 ± 0.9 (ORF1ab amplicon) and slope = 0.4 ± 0.2 and intercept = 15 ± 6 (RP amplicon). Notice that CT values determined for RP spans a smaller range. (b) Amplification efficiencies obtained in PK+HID samples (EPK+HID) relative to the corresponding purified RNA samples (Epurified RNA). The mean values obtained for Epurified RNA were: 1.98 ± 0.03 (N), 2.02 ± 0.06 (ORF1ab) and 1.94 ± 0.03 (RP). The median of each measurement is represented with a line in the bars and the lengths of these bars represent the standard error (N = 16).
Fig 4
Fig 4. Performance of PK+HID method in RT-qPCR determinations of the SARS-CoV-2 N, RdRp and E genes in randomly-selected clinical specimens.
Nasopharyngeal swab samples were processed for RNA extraction (purified RNA) or subjected to treatment with PK 1 mg/ml (55°C for 15 min) followed by heat-inactivation at 98°C for 5 min (PK+HID). The viral N, E and, RdRp genes and the human RP gene were amplified and detected by RT-qPCR. (a) CT values obtained for the same samples prepared by the two different methods, the line obtained by regression of the data (continuous lines) and 95% confidence bands (pink) are represented. RP plot also includes the data obtained in SARS-CoV-2 negative samples and spans a smaller CT range. The parameter values obtained from the fitting were: slope = 1.2 ± 0.1 and intercept = -5 ± 3 (N amplicon); slope = 0.7 ± 0.2 and intercept = 9 ±4 (RdRp amplicon); slope = 0.7 ± 0.1 and intercept = 7 ± 3 (E amplicon) and slope = 0.4 ± 0.1 and intercept = 16 ± 3 (RP amplicon). (b) Amplification efficiencies obtained in PK+HID samples (EPK+HID) relative to the corresponding purified RNA samples (Epurified RNA). The mean values obtained for Epurified RNA were: 1.94 ± 0.02 (N), 1.97 ± 0.02 (RdRp), 1.93 ± 0.03 (E) and 1.90 ± 0.03 (RP). The median of each measurement is represented with a line in the bars and the lengths of these bars represent the standard error (N = 8).

Similar articles

Cited by

References

    1. Kucharski AJ, Klepac P, Conlan AJK, Kissler SM, Tang ML, Fry H, et al.. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study. Lancet Infect Dis. 2020. Epub 2020/06/20. 10.1016/S1473-3099(20)30457-6 . - DOI - PMC - PubMed
    1. Guglielmi G. The explosion of new coronavirus tests that could help to end the pandemic. Nature. 2020;583(7817):506–9. Epub 2020/07/19. 10.1038/d41586-020-02140-8 . - DOI - PubMed
    1. Esbin MN, Whitney ON, Chong S, Maurer A, Darzacq X, Tjian R. Overcoming the bottleneck to widespread testing: a rapid review of nucleic acid testing approaches for COVID-19 detection. Rna. 2020;26(7):771–83. Epub 2020/05/03. 10.1261/rna.076232.120 - DOI - PMC - PubMed
    1. Akst J. RNA Extraction Kits for COVID-19 Tests Are in Short Supply in US. The Scientist Magazine. 2020 Mar 11, 2020.
    1. Slabodkin G. FDA chief warns of supply ’pressure’ on reagents for coronavirus tests. MedTech Dive Magazine. 2020 March 12, 2020.

Publication types

Substances

Supplementary concepts